Since Kinase inhibitors have proven to be efficacious and approvable targets, fuelling recent investment into this exciting space as their therapeutic targeting is explored beyond oncology. However, increasing resistance to existing programs and safety bottlenecks threaten further progress. The next wave of kinase targets depends on innovation.

Join the 2nd Next Generation Kinase Inhibitors Summit to connect with experts across discovery, R&D, and clinical medicine to discuss how to accelerate the next generation of kinase inhibitor drugs to market, which displays maximal therapeutic efficacy and durable clinical responses.

Key Topics:

• Assay Development, Kinome Exploration & and Kinase-Focussed Drug Discovery Principles
• Overcoming Tumor Resistance, Managing the Tumor Microenvironment, and Improving Durability
• Exploiting the RAS/MAPK Signalling Pathway
• Multikinase and Combination Therapies to Overcoming Resistance
• Targeting Established Pharmacological Mechanisms in Alternative Indications Beyond Oncology to Meet Unmet Needs

Don’t miss this opportunity to join & network with 100+ Kinase Biology Experts under one roof, hear from 18+ expert speakers from the space and showcase your work at the Scientific Poster Session.

This meeting is FREE for drug developers and researchers!

To know more visit: https://ter.li/sreltb